New England

EyePoint Pharmaceuticals to Host Virtual Key Opinion Leader (KOL) Event on November 9, 2023

Retrieved on: 
Tuesday, October 31, 2023
Therapy, Keck School of Medicine of USC, Assistant, AMD, Consultant, Partnership, KOL, Medicine, University, Baystate Health, Massachusetts Medical Society, University of Southern California, Patient, Retina, New England, Pharmaceutical industry, Hospital, Ophthalmology

WATERTOWN, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with retinal diseases, today announced it will host a virtual key opinion leader (KOL) event on Thursday, November 9, 2023 from 8:00 to 9:00 am ET.

Key Points: 
  • WATERTOWN, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with retinal diseases, today announced it will host a virtual key opinion leader (KOL) event on Thursday, November 9, 2023 from 8:00 to 9:00 am ET.
  • This event will focus on the potential of EYP-1901 in wet age-related macular degeneration (wet AMD), including KOL perspectives on the current wet AMD treatment landscape, vorolanib’s unique mechanism of action and outcome considerations for the upcoming topline data read-out for the DAVIO 2 trial in December.
  • A live audio webcast of the event can be accessed via the Investors section of the Company website at www.eyepointpharma.com .
  • A webcast replay will also be available on the corporate website at the conclusion of the call.

Gannex Published Phase I Data of ASC42, a Novel Farnesoid X Receptor Agonist on the Journal Drugs in R&D

Retrieved on: 
Monday, November 6, 2023
TC, PD, UDCA, Hepatology, Ursodeoxycholic acid, AST, Primary biliary cholangitis, PBC, Pharmacokinetics, Phase, American Association for Geriatric Psychiatry, NASH, GGT, Medicine, Non-alcoholic fatty liver disease, FXR, NAFLD, Obeticholic acid, Safety, ALT, Patient, OCA, Diagnosis, FGF19, New England, Pharmaceutical industry, Gannex

In-house developed by Gannex, ASC42 is a novel non-steroidal, selective, potent FXR agonist with best-in-class potential and global intellectual property.

Key Points: 
  • In-house developed by Gannex, ASC42 is a novel non-steroidal, selective, potent FXR agonist with best-in-class potential and global intellectual property.
  • On July 20, 2023, Gannex announced the completion of patient enrollment for Phase II clinical trial of ASC42 for PBC.
  • The Phase II clinical trial of Gannex's in-house developed farnesoid X receptor agonist ASC42 will be completed soon.
  • The topline data of the Phase II clinical trial are expected to be released by the end of 2023.

PKF O'Connor Davies Welcomes Michelle Skrobacz as Partner

Retrieved on: 
Friday, November 3, 2023
Southern New England School of Law, Certified Public Accountant, Face, PKF, Boston University School of Law, Boston University School of Public Health, Business, Partner, Western Connecticut State University, New England, Law, Accounting

NEW YORK, Nov. 3, 2023 /PRNewswire-PRWeb/ -- PKF O'Connor Davies, one of the nation's largest accounting, tax and advisory practices, today announced that it has hired Michelle Skrobacz as Partner. With over 20 years of tax and senior leadership experience, Skrobacz joins the organization's Private Client Services Group, whose clients include high-net-worth individuals and families, trusts, and private foundations, among others. She will be based out of the Boston, Massachusetts, office.

Key Points: 
  • NEW YORK, Nov. 3, 2023 /PRNewswire-PRWeb/ -- PKF O'Connor Davies, one of the nation's largest accounting, tax and advisory practices, today announced that it has hired Michelle Skrobacz as Partner.
  • "Michelle is a seasoned professional with decades of experience serving private clients and helping them identify tax planning opportunities and navigate the specific tax challenges they face," said Laurie J. Austin, PKF O'Connor Davies' New England Co-Managing Partner.
  • Prior to joining PKF O'Connor Davies, Skrobacz held a tax-focused management role with a financial advisory firm.
  • "Joining PKF O'Connor Davies offers the chance to take the next step in my career and expand my work with private clients," said Skrobacz.

TEAMSTERS LOCAL 251 OVERWHELMINGLY RATIFIES CONTRACT WITH BALLY'S TWIN RIVER CASINO

Retrieved on: 
Thursday, November 2, 2023
Teamsters Local 1932, International Brotherhood of Teamsters, Life, Local, Bally, Teamster, Retirement, New England, Pension fund, Twin River

EAST PROVIDENCE, R.I., Nov. 2, 2023 /PRNewswire/ -- Teamsters Local 251 members who work as maintenance staff and valets have overwhelmingly ratified agreements with Bally's Twin River Lincoln Casino Resort.

Key Points: 
  • EAST PROVIDENCE, R.I., Nov. 2, 2023 /PRNewswire/ -- Teamsters Local 251 members who work as maintenance staff and valets have overwhelmingly ratified agreements with Bally's Twin River Lincoln Casino Resort.
  • Along with a pension, all Teamsters working at the Twin River property are now entitled to employer-funded Teamster health care.
  • "The new contract includes top-notch Teamsters health care and a defined pension, so we can take care of our families now and have dignity in retirement," said Doug Baima, a Local 251 valet member at Twin River.
  • "The significant wins achieved at the table mean Teamsters will enjoy the strongest compensation package in the decades-long history of Local 251 at Twin River."

MARK WAHLBERG'S FUNCTIONAL ATHLEISURE BRAND MUNICIPAL PARTNERS WITH NEW ENGLAND PATRIOTS LINEBACKER, MATTHEW JUDON

Retrieved on: 
Thursday, November 2, 2023
NFL, New England Patriots, Partnership, Entrepreneurship, Heart, New England, Life, Tourism, Patriot

LOS ANGELES, Nov. 2, 2023 /PRNewswire/ -- MUNICIPAL, a premium performance, comfort, and style-driven apparel brand co-founded by Mark Wahlberg, is thrilled to announce its first official NFL partnership with New England Patriots linebacker, Matthew Judon.

Key Points: 
  • LOS ANGELES, Nov. 2, 2023 /PRNewswire/ -- MUNICIPAL , a premium performance, comfort, and style-driven apparel brand co-founded by Mark Wahlberg, is thrilled to announce its first official NFL partnership with New England Patriots linebacker, Matthew Judon.
  • The synergy between Judon and MUNICIPAL is not only rooted in Judon's long-standing admiration for the brand, but also in the shared connection to the Boston community.
  • "I chose to partner with MUNICIPAL because of their values and community goals," said Judon.
  • "MUNICIPAL has always stood for pushing boundaries and overcoming obstacles, and that's exactly what Matthew embodies on the gridiron.

Complete Genomics demonstrates technical and commercial momentum in the sequencing market through new customers, partnerships and collaborations less than one year after launching in the U.S.

Retrieved on: 
Tuesday, October 31, 2023
Complete Genomics, ASHG, RNA-Seq, Nebula Genomics, Karkus, G400, Whole genome sequencing, IDT, Medical laboratory, Bio-Rad Laboratories, RNA, University of Massachusetts, Face, Professor, Research, SNP, Society, American Society of Human Genetics, Ecosystem, Partnership, WGS, Human genetics, Google AI, Sequoia, Integrated DNA Technologies, Automation, New England Biolabs, Integration, New England, Completeness, Stanford University School of Medicine, Antibiotics, Medical device, Genomics

At ASHG, Complete Genomics will highlight experts from Stanford Medicine, UMass Chan Medical School and Praxis Genomics to discuss how affordable and accurate genomic sequencing is changing the face of research.

Key Points: 
  • At ASHG, Complete Genomics will highlight experts from Stanford Medicine, UMass Chan Medical School and Praxis Genomics to discuss how affordable and accurate genomic sequencing is changing the face of research.
  • See the full description of speakers Complete Genomics is bringing to ASHG at completegenomics.com/ashg-2023-event-page .
  • Based in San Jose, CA, Complete Genomics celebrated its U.S. commercial launch of its DNBSEQ™ sequencing product line one year ago at ASHG 2022.
  • "Our collaboration with Complete Genomics underscores our commitment to providing researchers with advanced solutions for sequencing applications."

FANATICS AND BINHO BOARD ANNOUNCE MLS SUBLICENSE DEAL

Retrieved on: 
Monday, October 30, 2023
Arsenal F.C., Liverpool F.C., Inter Miami CF, New York Red Bulls, LA Galaxy, FC Cincinnati, Columbus Crew, LAFC, NYCFC, Life, Real Salt Lake, Minnesota United FC, Sporting Kansas City, Houston Dynamo FC, Atlanta United FC, Partnership, Association football, MLS, CF Montréal, FC Dallas, Major League Soccer, Arsenal, D.C. United, Chicago Fire FC, Fanatics, Inc., Collection, Seattle Sounders FC, New England, Sport, College, Portland Timbers, New England Revolution

LOS ANGELES, Oct. 30, 2023 /PRNewswire/ - Fanatics, Inc. and Binho Board ( http://binhoboard.com ) have come together to announce a Major League Soccer sublicense deal that will bring the popular finger-flicking portable soccer style game to MLS fans!

Key Points: 
  • LOS ANGELES, Oct. 30, 2023 /PRNewswire/ - Fanatics, Inc. and Binho Board ( http://binhoboard.com ) have come together to announce a Major League Soccer sublicense deal that will bring the popular finger-flicking portable soccer style game to MLS fans!
  • Created back in 2018 by former College athlete Nick Witherill in his backyard, the Binho Board has quickly become the go-to tabletop competition game around the world working with some of the biggest soccer/football clubs including Liverpool FC, Arsenal FC and now teams here in America.
  • In a statement on the new partnership, Witherill commented, "I'm super excited to be partnered with the MLS and be able to bring each team's brand to life through our boards and products.
  • The new Fanatics / Soccer United Marketing LLC collection is available now at: https://binhoboard.com/collections/mls-collection
    For further information / media inquires: Zack Teperman - ZTPR - [email protected]

Dean College Brings AIDS Quilt to Campus in Conjunction with "RENT"

Retrieved on: 
Monday, October 16, 2023
Multimedia, Continuing the Conversation, Conversation, College, Student, Hope, Franklin Public Library (Massachusetts), VCU School of the Arts, School, Anger, Communication, Culture, Social responsibility, Sociology, HIV, Survival, RENT, Second National March on Washington for Lesbian and Gay Rights, Love, Trauma, AIDS, History, Boston Conservatory at Berklee, Literature, The arts, Fear, Crime, The Play That Goes Wrong, Dean College, NAMES Project AIDS Memorial Quilt, Sisters in Crime, HIV/AIDS, Berklee College of Music, New England, Nightclub, Tourism, Quilt, Dean

FRANKLIN, Mass. , Oct. 16, 2023 /PRNewswire/ -- Dean College is proud to display a section of the AIDS Memorial Quilt on campus from November 14-15, 2023, leading up to the premiere of the School of the Arts production of "RENT" on November 15.

Key Points: 
  • , Oct. 16, 2023 /PRNewswire/ -- Dean College is proud to display a section of the AIDS Memorial Quilt on campus from November 14-15, 2023, leading up to the premiere of the School of the Arts production of "RENT" on November 15.
  • The AIDS Memorial Quilt is a living memorial to a generation lost to AIDS, an important HIV prevention education tool and the largest community arts project in history.
  • Individuals and groups create Quilt panels to honor, remember and celebrate the stories and lives of those lost to HIV/AIDS.
  • "The AIDS Memorial Quilt was built out of one of these moments of protest and demand for those lost to be remembered.

SightMD Welcomes Taylor Rado, OD to its expert team in New York

Retrieved on: 
Monday, October 2, 2023
Contact, Glaucoma, New England, American Optometric Association, Surgeon, Macular degeneration, Friends, OD, New England College, New England College of Optometry, Patient, Woodbury, Diabetic retinopathy, Union College, Family, Commerce, Nursing, Neuroscience, Optometry, Growth

HAUPPAUGE, N.Y., Oct. 2, 2023 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Taylor Rado, OD to its expert team.

Key Points: 
  • SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Taylor Rado, OD to its expert team.
  • HAUPPAUGE, N.Y., Oct. 2, 2023 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Taylor Rado, OD to its expert team.
  • Dr. Taylor Rado is a board certified optometrist who enjoys providing comprehensive eye care, fitting contact lenses, and managing post-op care in collaboration with the other providers at SightMD.
  • She then went on to complete her Doctor of Optometry degree at the New England College of Optometry in Boston, Massachusetts.

Exergy and Acuity Enter into a Strategic Partnership in the New-England Life-Sciences Market

Retrieved on: 
Tuesday, September 5, 2023
Transfer, New England, Maintenance, Exergy, Point, Partnership, Purex, Safety, Recycling, Acuity

As a trusted partner, Exergy is excited to collaborate with Acuity to produce innovative solutions that enhance safety and enable their clients to achieve greater operational efficiency and success.

Key Points: 
  • As a trusted partner, Exergy is excited to collaborate with Acuity to produce innovative solutions that enhance safety and enable their clients to achieve greater operational efficiency and success.
  • Our mutual commitment to excellence is at the core of this partnership, which brings together Acuity's pharmaceutical and biomanufacturing expertise with Exergy's cutting-edge heat-transfer technologies.
  • By working with Exergy and Acuity, end users benefit by having a comprehensive team of heat-transfer specialists both at the factory and in the field.
  • Our partnership also extends to the design of control and automation systems, which can deliver significant energy savings and process efficiencies when implemented effectively.